Sai Life Sciences
SAILIFE · Pharma > Pharmaceuticals & Drugs Listing date: Dec. 18, 2024

Stock Price vs Company Growth
1d
1.1%
1w
1.2%
1m
2.9%
3m
25.4%
6m
27.3%
1y
56.1%
all
35.5%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 1,228 1.1%
944
1,261
Company Overview

Sales
2,192 Cr
Growth: 26.4%
Profit after Tax
349 Cr
Growth: 4.7%
Mid Cap
26,071 Cr
P/E: 74.8x
Industry P/E: 33.7x
Fundamentals

Sales (Cr) ₹ 2,192
Growth 26.4%
EBITDA 28.8%
P/S 11.8x
Dividend 0.0%
P/E 74.8x
Book Value ₹ 117
PEG Ratio 2.9x
ROE 15.0%
P/B 10.5x
Shareholding Pattern

Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed

The company is a pure play fully-integrated, innovator-focused, contract research, development and manufacturing organization. It provides end-to-end services across the drug discovery, development and manufacturing value chain for small molecule new chemical entities to global pharmaceutical innovators companies and biotechnology firms.
Followers (1)